Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9636388 Multi-indication mRNA cancer immunotherapy

Patent 9636388 was granted and assigned to Morphogenesis, Inc. on May, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 19 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11873327 Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11850262 Compositions and methods for CAR T cell therapy
0
Edits on 6 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 6 Dec, 2023
Edits made to:
Article (+424 characters)
Article

Patent abstract

Synthetic bacterial messenger RNA can be used to prepare autologous, allogenic or direct nucleic acid cancer vaccines. Cancer cells are transfected either in vitro or in vivo with mRNA obtained from DNA that encodes an immunogenic bacterial protein. An immune response to the cancer is generated from direct administration of the mRNA in vivo or administration of vaccines prepared from cancer cells in vitro.

Edits on 11 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11779602 Methods of use for CAR T cells
Edits on 20 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11759480 Compositions and methods for CAR T cell therapy
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0963638800
Edits on 24 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09636388 Multi-indication mRNA cancer immunotherapy US Patent 9636388 Multi-indication mRNA cancer immunotherapy

Infobox
Patent Number
0963638800
Patent Number
963638800
Edits on 31 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
096363880
Date of Patent
May 2, 2017
0
Patent Application Number
151149430
Date Filed
May 19, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=096363880
Patent Primary Examiner
Quang Nguyen
Quang Nguyen
0
Edits on 5 Oct, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
096363880
Date of Patent
May 2, 2017
0
Patent Application Number
151149430
Date Filed
May 19, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=096363880
Patent Primary Examiner
Quang Nguyen
Quang Nguyen
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09636388
Edits on 12 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09636388 Multi-indication mRNA cancer immunotherapy

Infobox
Is a
Patent
Patent
Patent applicant
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09636388
Date of patent
May 2, 2017
Patent application number
15114943
Date Filed
May 19, 2016
Patent primary examiner
Quang Nguyen
Quang Nguyen

Find more entities like US Patent 9636388 Multi-indication mRNA cancer immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.